SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
8633143
Source:
http://linkedlifedata.com/resource/pubmed/id/8633143
Search
Subject
(
66
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0034107
,
umls-concept:C0036043
,
umls-concept:C0166237
,
umls-concept:C0178602
,
umls-concept:C0205390
,
umls-concept:C1261322
,
umls-concept:C1516634
,
umls-concept:C1519249
,
umls-concept:C1547011
,
umls-concept:C1879746
pubmed:issue
1
pubmed:dateCreated
1996-6-28
pubmed:abstractText
To investigate the efficacy of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA) in the detection of focal liver lesions with respect to dose, side effects, and pulse sequence.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0401260
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Contrast Media
,
http://linkedlifedata.com/resource/pubmed/chemical/Gadolinium
,
http://linkedlifedata.com/resource/pubmed/chemical/Gadolinium DTPA
,
http://linkedlifedata.com/resource/pubmed/chemical/Organometallic Compounds
,
http://linkedlifedata.com/resource/pubmed/chemical/Pentetic Acid
,
http://linkedlifedata.com/resource/pubmed/chemical/gadolinium ethoxybenzyl DTPA
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0033-8419
pubmed:author
pubmed-author:BalzerTT
,
pubmed-author:Beri?MM
,
pubmed-author:DaldrupH EHE
,
pubmed-author:HesslSS
,
pubmed-author:PetersP EPE
,
pubmed-author:ReimerPP
,
pubmed-author:RummenyE JEJ
,
pubmed-author:ShamsiKK
,
pubmed-author:TombachBB
pubmed:issnType
Print
pubmed:volume
199
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
177-83
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:8633143-Contrast Media
,
pubmed-meshheading:8633143-Dose-Response Relationship, Drug
,
pubmed-meshheading:8633143-Double-Blind Method
,
pubmed-meshheading:8633143-Female
,
pubmed-meshheading:8633143-Gadolinium
,
pubmed-meshheading:8633143-Gadolinium DTPA
,
pubmed-meshheading:8633143-Humans
,
pubmed-meshheading:8633143-Liver
,
pubmed-meshheading:8633143-Liver Diseases
,
pubmed-meshheading:8633143-Liver Neoplasms
,
pubmed-meshheading:8633143-Magnetic Resonance Imaging
,
pubmed-meshheading:8633143-Male
,
pubmed-meshheading:8633143-Middle Aged
,
pubmed-meshheading:8633143-Organometallic Compounds
,
pubmed-meshheading:8633143-Pentetic Acid
,
pubmed-meshheading:8633143-Time Factors
pubmed:year
1996
pubmed:articleTitle
Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence.
pubmed:affiliation
Institute of Clinical Radiology, Westfalian Wilhelms-University Muenster, Germany.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Comparative Study
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Clinical Trial, Phase II